On August 12, 2026, John Victor Oyler sold 713,596 ordinary shares (represented by 54,892 American Depositary Shares) of BeOne Medicines Ltd. at an average price of USD 27.55 per share, involving about USD 19.66 million. The sale was effected pursuant to a Rule 10b5-1 trading plan.
Prior to the disposal, Mr. Oyler's long position in BeOne Medicines was 59.56 million shares, representing 3.86%; following the disposal, the holding changed to 58.85 million shares, with the long position ratio falling to 3.82%.
Source: Hong Kong Exchanges and Clearing Limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments